INmune Bio Inc. (INMB)
undefined
undefined%
At close: undefined
4.75
-0.46%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -30.01M -27.30M -30.34M -12.10M -7.68M -12.44M -831.49K -277.49K -48.87K
Depreciation & Amortization - - - - - - - - -
Stock-Based Compensation 7.37M 7.15M 4.80M 3.11M 4.10M 10.00M 199.56K - 120.00K
Other Working Capital 1.70M -4.27M -5.35M -1.03M -129.21K -134.38K -218.81K -309.95K 750.00
Other Non-Cash Items 224.00K 328.00K 126.00K 3.19M -1.54M 9.81M -150.00K 50.00K 30.00K
Deferred Income Tax - - - - - - - - -
Change in Working Capital 10.44M -2.86M -3.09M 43.51K -260.88K 379.67K 20.10K -89.89K 750.00
Operating Cash Flow -11.98M -22.69M -28.50M -8.94M -5.38M -2.06M -761.83K -317.38K -18.12K
Capital Expenditures - - -15.00M - - - -100.00K - -
Acquisitions - - - - - - - - -
Purchase of Investments - - - - - - - - -
Sales Maturities Of Investments - - - - - - - - -
Other Investing Acitivies - - -15.00M - - - -100.00K - -
Investing Cash Flow - - -15.00M - - - -100.00K - -
Debt Repayment -5.00M - 14.95M - - - - - -
Common Stock Repurchased - - - -1.01M - - - - -
Dividend Paid - - - - - - - - -
Other Financial Acitivies - 30.00K 1.15M - - - - 350.00K 120.00K
Financial Cash Flow -4.22M 729.00K 96.36M 23.89M 12.21M 900.00K 2.06M 450.00K 30.00K
Net Cash Flow -16.30M -22.66M 52.84M 14.97M 6.81M -1.18M 1.23M 129.78K 11.88K
Free Cash Flow -11.98M -22.69M -43.50M -8.94M -5.38M -2.06M -861.83K -317.38K -18.12K